Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (PIE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Amgen
Novartis
Information provided by (Responsible Party):
Amanda Townsend, The Queen Elizabeth Hospital
ClinicalTrials.gov Identifier:
NCT01139138
First received: May 28, 2010
Last updated: February 8, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)